文献速递前列腺癌

根治性前列腺切除术后晚期生化复发与更慢进展相关

Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.
PubMed 文献 · BJU Int · 2018-10-19

该研究基于2003–2017年2312例接受根治性前列腺切除术的局限性前列腺癌患者队列,按术后生化复发时间分组分析。446例术后5年PSA不可测者中11.7%出现生化复发,晚期复发者肿瘤分级更高、前列腺外侵犯率更高、肿瘤体积更大;RP ISUP分级组是晚期生化复发的显著预测因素。

要点

  • 术后5年PSA不可测患者中11.7%仍出现晚期生化复发。
  • 晚期复发者ISUP分级、Gleason评分、前列腺外侵犯率及肿瘤体积更高。
  • RP ISUP分级组是生化复发的显著预测因素(OR 2.14,95%CI 1.43–3.20,P<0.001)。

核心结论

  • RP ISUP分级组是晚期生化复发的强预测指标。
  • 生化复发时机处于风险连续谱上,休眠微转移概念需进一步研究。

研究设计与样本

  • 回顾性队列研究,纳入2003–2017年接受RP的局限性前列腺癌患者2312例,随访至多12年。

主要发现

  • 446例术后5年PSA不可测患者中11.7%出现生化复发。
  • 晚期复发者ISUP分级和Gleason评分显著更高(P<0.001和P=0.001)。
  • 晚期复发者前列腺外侵犯率更高(P=0.022),肿瘤体积更大(P=0.032)。
  • RP ISUP分级组预测生化复发OR 2.14(95%CI 1.43–3.20,P<0.001)。

临床怎么用

  • 术后5年PSA不可测者仍需关注晚期生化复发风险。
  • RP ISUP分级组可用于识别晚期生化复发高危患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterise the pattern of late biochemical recurrence (BCR) in the largest contemporary cohort of patients with localised prostate cancer treated with radical prostatectomy (RP) in the active surveillance era. PATIENTS AND METHODS: Consecutive patients who underwent RP for localised prostate cancer between 2003 and 2017 were identified from a prospectively recorded, dedicated prostate cancer database. Patients who received neoadjuvant androgen-deprivation therapy were excluded. These patients were categorised into the following groups: no BCR, BCR at <12 months (early), BCR at 12-60 months (intermediate), and BCR at >60 months (late), after RP. Clinicopathological characteristics were analysed using the Student's t-test, Mann-Whitney U-test, or chi-squared test where appropriate. Multivariable binomial logistic regression models were used to assess predictors of BCR at various time-points. RESULTS: In all, 2312 patients were included in the final analysis with up to 12 years of follow-up data. The average patient had clinically localised prostate cancer, an elevated PSA level, and International Society of Urological Pathology (ISUP) Grade Group 2 on biopsy. In all, 88.7% of patients had ISUP Grade Group ≥2 at RP. A subgroup of 446 patients had undetectable PSA levels at 5 years after RP; 11.7% of them progressed to experience BCR. In this subgroup, late recurrers had significantly higher-grade tumours on ISUP and Gleason sum (P <0.001 and P = 0.001, respectively), higher rates of extraprostatic extension (P = 0.022), and larger tumour volumes (P = 0.032). Logistic regression showed that RP ISUP Grade Group was a significant predictor of BCR (odds ratio 2.14, 95% confidence interval 1.43-3.20; P <0.001). CONCLUSION: This study characterises the pattern of late BCR in the largest contemporary active surveillance era cohort. We have identified that RP ISUP Grade Group is a strong predictive indicator for late BCR. We also propose that timing of BCR resides on a continuum of risk and that the potential concept of dormant micrometastatic involvement requires further research and evaluation.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Chow K, Herrera P, Stuchbery R, et al. Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression. BJU Int. 2018. PMID: 30248237. doi:10.1111/bju.14556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。